Zahid Ahmad (@dr_zahid_ahmad) 's Twitter Profile
Zahid Ahmad

@dr_zahid_ahmad

Endocrinologist and Lipid Specialist at UT Southwestern; @halalpitmasters

ID: 951267439244922880

calendar_today11-01-2018 01:40:05

379 Tweet

471 Followers

479 Following

Katherine Wilemon (@kawilemon) 's Twitter Profile Photo

A9: We have many medication options beyond statins, and more are in development. These exciting innovations mean that doctors can really personalize treatment for patients with FH! This is called precision health and can help patients have better health outcomes. #KnowFH

A9: We have many medication options beyond statins, and more are in development. These exciting innovations mean that doctors can really personalize treatment for patients with FH! This is called precision health and can help patients have better health outcomes. #KnowFH
National Lipid Association (@nationallipid) 's Twitter Profile Photo

šŸ•‘ Last chance to register for our free, impactful webinar! Join us tomorrow, 11/8 at 1pm ET as Zahid Ahmad dives into ā€œBALANCE and PALISADE: New Triglyceride-Lowering Drugs.ā€ Don’t miss this expert insight into the latest in lipid management! us02web.zoom.us/meeting/regist…

šŸ•‘ Last chance to register for our free, impactful webinar! Join us tomorrow, 11/8 at 1pm ET as <a href="/Dr_Zahid_Ahmad/">Zahid Ahmad</a> dives into ā€œBALANCE and PALISADE: New Triglyceride-Lowering Drugs.ā€ Don’t miss this expert insight into the latest in lipid management! 
us02web.zoom.us/meeting/regist…
Sam Tsimikas, MD (@lpa_doc) 's Twitter Profile Photo

I have noted this previously. The journal could have asked for additional genetic testing, it's possible there is a second hit, like beta-sitosterolemia. Either way, this is a poor prognostic sign and the same deposits may also be accumulating in the vessels wall. Needs rapid

I have noted this previously. The journal could have asked for additional genetic testing, it's possible there is a second hit, like beta-sitosterolemia.  Either way, this is a poor prognostic sign and the same deposits may also be accumulating in the vessels wall. Needs rapid
Zahid Ahmad (@dr_zahid_ahmad) 's Twitter Profile Photo

Screening blood donors for triglycerides! 10,000 people screened in only 2-3 weeks! authors.elsevier.com/c/1kUbL6tb2EA0…

National Lipid Association (@nationallipid) 's Twitter Profile Photo

EXCITING NEWSā€¼ļø The Mastering Triglyceride Science course is back at #NLASessions 2025! Deepen your expertise in severe hypertriglyceridemia & the latest therapies. Join us May 29 in Miami or via livestream. šŸ”—Learn more & register: lipid.org/mastering-trig…

EXCITING NEWSā€¼ļø

The Mastering Triglyceride Science course is back at #NLASessions 2025! Deepen your expertise in severe hypertriglyceridemia &amp; the latest therapies. Join us May 29 in Miami or via livestream.

šŸ”—Learn more &amp; register: lipid.org/mastering-trig…
National Lipid Association (@nationallipid) 's Twitter Profile Photo

Attention health care professionals!šŸ“£ Enhance your expertise in hypertriglyceridemia management with the NLA’s Mastering Triglycerides course, led by Zahid Ahmad & additional faculty. 🌟Join us in person at #NLASessions OR online May 29. Register: lipid.org/mastering-trig…

Daniel Ambinder, MD (@dr_danmd) 's Twitter Profile Photo

šŸ„› Ep 414: CardioNerds Case Report – Got Milky Blood? Spencer Weintraub MD, DipABLM Mike Albosta Anna Biggins & Zahid Ahmad unpack hypertrig presenting with abdominal pain Mentored by Dr. Dan Soffer & Eugenia Gianos MD In collaboration with National Lipid Association cardionerds.com/414-case-repor…

Pablo Corral MD (@drpablocorral) 's Twitter Profile Photo

It no longer matters whether JACC Journals retracts the KETO-CTA paper or rewrites it. The damage is done. What will remain is the undeniable fact that a group of individuals—posing as scientists—tried to fabricate credibility for a failed hypothesis by manipulating data and

It no longer matters whether <a href="/JACCJournals/">JACC Journals</a> retracts the KETO-CTA paper or rewrites it. 

The damage is done. 

What will remain is the undeniable fact that a group of individuals—posing as scientists—tried to fabricate credibility for a failed hypothesis by manipulating data and
Eugenia Gianos MD (@eugeniagianos) 's Twitter Profile Photo

Great to meet our newest cohort of National Lipid Association #LipidScholars tonight. Thanks to our grads, scholars & mentors for welcoming our new class! Thanks to Zahid Ahmad for being an inspirational co-chair & Brian Carpenter for building an awesome program!

National Lipid Association (@nationallipid) 's Twitter Profile Photo

Familial Chylomicronemia (FCS) is frequently misdiagnosed and often mistaken for Multifactorial Chylomicronemia (MCS), which occurs more often and is less severe. Phenotypes may overlap, but management differs! 🚨Let’s talk about FCS vs MCS!

Amit Khera (@dramitkhera) 's Twitter Profile Photo

Today we were honored to have former UTSW Cardiology Fellowship and UTSW Heart faculty Clyde Yancy, MD, MSc provide the inaugural Daniel Foster Lecture for UTSW Internal Medicine Grand Rounds. Amazing clinician, leader, educator, and human. Glad to have you back home!

Today we were honored to have former <a href="/UTSWCardfellow/">UTSW Cardiology Fellowship</a> and <a href="/utswheart/">UTSW Heart</a> faculty <a href="/NMHheartdoc/">Clyde Yancy, MD, MSc</a>  provide the inaugural Daniel Foster Lecture for <a href="/UTSWInternalMed/">UTSW Internal Medicine</a> Grand Rounds.  Amazing clinician, leader, educator, and human. Glad to have you back home!
National Lipid Association (@nationallipid) 's Twitter Profile Photo

The NLA and Foundation of the NLA urge CMSGov and DrOzCMS to include LDL-C measurement in CMS quality measurement programs. Effective LDL-C management is key to reducing ASCVD, the leading cause of death in the U.S. Read more: ow.ly/tje450VV66J Dr. James Underberg Christie Ballantyne

The NLA and <a href="/foundationofnla/">Foundation of the NLA</a> urge <a href="/CMSGov/">CMSGov</a> and <a href="/DrOzCMS/">DrOzCMS</a> to include LDL-C measurement in CMS quality measurement programs. Effective LDL-C management is key to reducing ASCVD, the leading cause of death in the U.S. 

Read more: ow.ly/tje450VV66J

<a href="/lipiddoc/">Dr. James Underberg</a> <a href="/CBallantyneMD/">Christie Ballantyne</a>